Fat Distribution in Schizophrenia Patients: A Pilot Study Comparing First- and Second-Generation Antipsychotics. Issue 1 (February 2018)
- Record Type:
- Journal Article
- Title:
- Fat Distribution in Schizophrenia Patients: A Pilot Study Comparing First- and Second-Generation Antipsychotics. Issue 1 (February 2018)
- Main Title:
- Fat Distribution in Schizophrenia Patients
- Authors:
- Sapra, Mamta
Lawson, Donna
Iranmanesh, Ali - Abstract:
- Abstract: Background: Introduction of second-generation antipsychotics (SGAs) has reduced neurologic toxicity but are associated with increased weight gain and obesity. The objective of this pilot study is to compare the effects of first-generation antipsychotics (FGAs) and SGAs in patients with schizophrenia on body fat and presumed concomitant metabolic parameters. Methods: Study compared schizophrenia nondiabetic men treated with FGAs (group 1, n = 5) and men treated with SGAs (group 2, n = 9). Each subject completed psychiatric and endocrine evaluation including severity of psychiatric symptoms, adverse effects, body weight, body composition, and measurements of glucose, insulin, adipokines, and inflammatory markers. Student t test was used for statistical analysis. Results: Men treated with FGAs had a lower mean body mass index with a trend toward statistical significance (25.3 ± 1.4 vs 29.3 ± 1.7, P = 0.06). Treatment with FGAs was associated with lower waist/height ratio (0.55 ± 0.02 vs 0.62 ± 0.02, P = 0.036) and android fat mass index (0.62 ± 0.01 vs 0.96 ± 0.1, P = 0.03). Homeostasis Model Assessment for insulin resistance values were suggestive of significantly lower peripheral insulin resistance in men treated with FGAs (0.92 ± 0.15 vs 2.3 ± 0.34, P = 0.014). Conclusions: The results of this study are significant for decreased peripheral insulin resistance in men treated with SGAs in a setting of no significant age difference and only a trend toward higher bodyAbstract: Background: Introduction of second-generation antipsychotics (SGAs) has reduced neurologic toxicity but are associated with increased weight gain and obesity. The objective of this pilot study is to compare the effects of first-generation antipsychotics (FGAs) and SGAs in patients with schizophrenia on body fat and presumed concomitant metabolic parameters. Methods: Study compared schizophrenia nondiabetic men treated with FGAs (group 1, n = 5) and men treated with SGAs (group 2, n = 9). Each subject completed psychiatric and endocrine evaluation including severity of psychiatric symptoms, adverse effects, body weight, body composition, and measurements of glucose, insulin, adipokines, and inflammatory markers. Student t test was used for statistical analysis. Results: Men treated with FGAs had a lower mean body mass index with a trend toward statistical significance (25.3 ± 1.4 vs 29.3 ± 1.7, P = 0.06). Treatment with FGAs was associated with lower waist/height ratio (0.55 ± 0.02 vs 0.62 ± 0.02, P = 0.036) and android fat mass index (0.62 ± 0.01 vs 0.96 ± 0.1, P = 0.03). Homeostasis Model Assessment for insulin resistance values were suggestive of significantly lower peripheral insulin resistance in men treated with FGAs (0.92 ± 0.15 vs 2.3 ± 0.34, P = 0.014). Conclusions: The results of this study are significant for decreased peripheral insulin resistance in men treated with SGAs in a setting of no significant age difference and only a trend toward higher body mass index, but consistent documentation of increased abdominal fat by 3 different methodologies. Future studies involving larger number of subjects are warranted to verify the present findings. … (more)
- Is Part Of:
- Journal of clinical psychopharmacology. Volume 38:Issue 1(2018)
- Journal:
- Journal of clinical psychopharmacology
- Issue:
- Volume 38:Issue 1(2018)
- Issue Display:
- Volume 38, Issue 1 (2018)
- Year:
- 2018
- Volume:
- 38
- Issue:
- 1
- Issue Sort Value:
- 2018-0038-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2018-02
- Subjects:
- body composition -- antipsychotics -- schizophrenia
Psychopharmacology -- Periodicals
Psychopharmacology -- Periodicals
Psychopharmacologie -- Périodiques
Psychopharmacology
Periodicals
615.78 - Journal URLs:
- http://journals.lww.com/psychopharmacology/pages/default.aspx ↗
http://www.psychopharmacology.com ↗
http://136.142.56.160/ovidweb/ovidweb.cgi?T=JS&MODE=ovid&NEWS=N&PAGE=toc&D=ovid_ovft&AN=00004714-000000000-00000 ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/JCP.0000000000000810 ↗
- Languages:
- English
- ISSNs:
- 0271-0749
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4958.691000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9037.xml